Skip to content

Envoy Medical COCH Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin-310.7%-48.0pp-262.7%+31.6pp-294.2%-32.1pp-262.2%+22.3pp-284.4%-54.7pp
Operating margin-9,881.2%-641pp-9,240.7%+583pp-9,824%-951pp-8,873%+316pp-9,188.7%-630pp
Net margin-9,875.6%-18.4pp-9,857.3%+618pp-10,475%-896pp-9,579.3%-370pp-9,209%+33.3pp
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio2.3×+1.7×0.5×-0.1×0.6×-0.3×0.9×-0.2×1.1×-0.1×
Per Share
Book value per share$0.15+128%-$0.52-49.1%-$0.35+74.9%-$1.40-22.9%-$1.14-13.3%
Valuation
Market capitalization$61M+83.5%$19.13M+3.6%$18.47M-39.0%$30.28M+9.4%$27.68M-4.4%
Price / sales260.7×+111×79.4×-9.4×88.8×-47.6×136.4×+5.8×130.6×+1.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Envoy Medical's profit margins?
Envoy Medical (COCH) runs a -310.7% gross margin and a -9881.2% operating margin, with a -9875.6% net margin.
Where do Envoy Medical's ratios come from?
Every ratio is computed from Envoy Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.